Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Colorcon
Boehringer Ingelheim
Chinese Patent Office
Moodys
Medtronic
US Army
Johnson and Johnson
Covington

Generated: October 22, 2017

DrugPatentWatch Database Preview

EPANOVA Drug Profile

« Back to Dashboard

What is the patent landscape for Epanova, and when can generic versions of Epanova launch?

Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are eight patents protecting this drug.

This drug has eighty patent family members in thirty-eight countries.

The generic ingredient in EPANOVA is omega-3-carboxylic acids. There is one drug master file entry for this compound. Additional details are available on the omega-3-carboxylic acids profile page.

Summary for Tradename: EPANOVA

US Patents:8
Applicants:1
NDAs:1
Clinical Trials: see list15
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EPANOVA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► Subscribe ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► SubscribeY ► Subscribe
Astrazeneca Pharms
EPANOVA
omega-3-carboxylic acids
CAPSULE;ORAL205060-001May 5, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: EPANOVA

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,729,321Autonomous private key recovery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: EPANOVA

Country Document Number Estimated Expiration
Slovakia152397► Subscribe
Poland184085► Subscribe
Israel177462► Subscribe
Mexico2014008309► Subscribe
Germany69634693► Subscribe
China1929824► Subscribe
MexicoPA06008352► Subscribe
Japan2015503590► Subscribe
Canada2221356► Subscribe
United Kingdom0403247► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Healthtrust
QuintilesIMS
Cantor Fitzgerald
Federal Trade Commission
Chubb
Covington
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot